Pancreatic Adenocarcinoma Treatment Market Trends

Growth Drivers

• Increasing Prevalence of Pancreatic Disorders owing to Germline Mutations – In the U.S. more than 60,000 people are diagnosed with pancreatic cancer as of 2023.
• Rising Geriatric Population across the World with Reduced Immunity – As per the estimations in 2023, more than 1 in 6 people in America which is 80 million people are now the age 65 and above.
• Increasing Incidence of Cancers related to the Digestive System and Stomach owing to Unhealthy Foods – The number of cancer cases reported in the year 2019 across the U.S. was over 1,752,700 and 600,000 people died from cancer.
• Increasing use of Chemotherapy and Radiotherapy Treatments around the Globe – More than 50% of cancer patients are estimated to receive radiation therapy as of 2023 estimations.
• Rising Healthcare Expenditure with Improved Infrastructure Facilities – The healthcare expenditure of the U.S.  was estimated to increase by more than 25% in the year 2021 with a value of over USD 4 trillion.

Challenges

• Rising Cost of Drug Development and Treatment
• Side Effects of Radiation and Chemotherapy –

The side effects of chemotherapy include pain, dizziness, fever, vomiting, and frequent bowel movement and the side effects of radiation therapy include diarrhea, shortness of breath, change in taste, and urinary and bladder problems. All these factors are estimated to be the reason for the hampering of market growth.

• Stringent Government Regulatory Guidelines